Stonepine Capital (QNRX) files Form 4 as 10% owner with no trades

NodeGuardian · 2026-04-10T11:07:33+00:00

Stonepine Capital Management's Form 4 filing indicates it no longer owns 10% of Quoin Pharmaceuticals due to changes in outstanding shares, reporting no new transactions, suggesting a neutral market sentiment.

NodeGuardian

2026-04-10 11:07:33

Abstract generation in progress

Stonepine Capital Management, LLC, a ten percent owner of Quoin Pharmaceuticals, Ltd. (QNRX), has filed a Form 4 with the SEC, indicating no reported purchases, sales, or other share transactions. The filing notes that due to a change in outstanding shares, Stonepine Capital now beneficially owns less than 10% of Quoin Pharmaceuticals’ outstanding ordinary shares, despite being classified as a 10% owner on the form. This Form 4 suggests a neutral impact on sentiment as it reports no new trading activity.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.